Multitude Therapeutics out-licensed global rights (ex-Greater China) for its Tissue Factor ADC to Denmark’s Adcendo in a $1 billion agreement. Huadong Pharmaceutical acquired rights for two immune ...

Distant metastasis in head and neck cancer: Baseline factors. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not include a full text component.

Hyperhomocysteinemia in cancer patients with thrombosis is not associated with methylene tetrahydrofolate reductase (MTHFR) gene mutations is down regulated by low molecular weight heparin (LMWHs) ...

Traditional-tissue engineering approaches (Panel A) seed cells onto a three-dimensional biomaterial scaffold that serves as a framework for new tissue development (i). The scaffold degrades as new ...